Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
CATrends: Flea and Tick Products Marketed as Safe
Lawsuits allege products contain ingredients that are harmful to pets.
Lululemon’s ‘Be Planet’ Sustainability Campaign
Canadian law enforcement agency opens inquiry into apparel company’s green claims.
Sun-Maid Vanilla Yogurt Covered Raisins
Lawsuit alleges yogurt ingredient does not meet federal definition of yogurt.
What You Should Know about Nélo Life
What we learned upon taking a closer look at this new MLM.
FTC Should Ban Individual Impersonation Scams
TINA.org submits comment in support of FTC’s proposal to ban fake celebrity endorsements, romance scams and other impersonation scams.